| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/22/2010 | US20100183733 Hair growth-inhibiting agent |
| 07/22/2010 | US20100183679 Primers for detecting plasmodium |
| 07/22/2010 | US20100183656 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183633 Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition |
| 07/22/2010 | US20100183628 Random homozygous gene perturbation (rhgp) with thermal assymetric interlaced (tail)-pcr |
| 07/22/2010 | US20100183626 Human phospholipase a2 epsilon |
| 07/22/2010 | US20100183620 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 07/22/2010 | US20100183610 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183604 Preventive/remedy for cancer |
| 07/22/2010 | US20100183593 Gene Polymorphisms Predictive for Dual TKI Therapy |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183583 Galk1s as modifiers of the pten/akt pathway and methods of use |
| 07/22/2010 | US20100183582 Hemostatic compositions containing sterile thrombin |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183574 Lactic acid bacteria and their use in swine direct-fed microbials |
| 07/22/2010 | US20100183570 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | US20100183568 Method for production of hepatic-lobule-like cell cluster from adipose-tissue-derived cell |
| 07/22/2010 | US20100183566 METHOD FOR EFFICIENT TRANSFER OF HUMAN BLASTOCYST-DERIVED STEM CELLS (hBS CELLS) FROM A FEEDER-SUPPORTED TO A FEEDER-FREE CULTURE SYSTEM |
| 07/22/2010 | US20100183559 Bifidobacterium longum |
| 07/22/2010 | US20100183555 Methods and kits for determining drug sensitivity in patients infected with hcv |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183521 Methods of detecting and treating colon disorders |
| 07/22/2010 | US20100183520 Netrin-1 as a biomarker of injury and disease |
| 07/22/2010 | US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | US20100183512 Use of cthrc1 in diagnosing cancer of liver |
| 07/22/2010 | US20100183507 Tumor markers in ovarian cancer |
| 07/22/2010 | US20100181239 Integrated High Throughput System for the Analysis of Biomolecules |
| 07/22/2010 | US20100181035 Glucosyltransferases |
| 07/22/2010 | DE102009011253B3 Selektion kodierender Nukleinsäure-Konstrukte auf Abwesenheit von Frameshift-Mutationen Selection coding nucleic acid constructs in the absence of frameshift mutations |
| 07/22/2010 | CA2787218A1 Methods employing non-coding rna expression assays |
| 07/22/2010 | CA2753336A1 Integrated desktop software for management of virus data |
| 07/22/2010 | CA2749841A1 Methods of detecting cervical cancer |
| 07/22/2010 | CA2749821A1 Ets-2 biomarkers for fibrotic diseases and uses thereof |
| 07/22/2010 | CA2749783A1 Diagnosis and treatment of autism spectrum disorders |
| 07/22/2010 | CA2749693A1 Enzyme preparation containing thermostable dna polymerase, method for producing same, and method for detecting subject organism to be detected |
| 07/22/2010 | CA2749051A1 Methods for identifying patients who will respond well to cancer treatment |
| 07/21/2010 | EP2209075A1 Base sequence determination program, base sequence determination system and base sequence determination method |
| 07/21/2010 | EP2208986A1 Method of determining autoinducer-2 |
| 07/21/2010 | EP2208798A1 MicroRNA (miRNA) for the diagnosis and treatment of heart diseases |
| 07/21/2010 | EP2208797A2 Methods, compositions and kits for use in polynucleotide amplification |
| 07/21/2010 | EP2208796A2 Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
| 07/21/2010 | EP2208795A1 Nucleic acid detection method, and nucleic acid detection kit |
| 07/21/2010 | EP2208794A1 Method and kit for quantification of small, dense ldl cholesterol |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208789A1 DNA polymerases having improved labeled nucleotide incorporation properties |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2207903A1 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 07/21/2010 | EP2207902A1 A method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon |
| 07/21/2010 | EP2207900A1 Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequencing by synthesis |
| 07/21/2010 | EP2207899A2 Assembly of large nucleic acids |
| 07/21/2010 | EP2207898A2 Frameless multiplexed microarrays |
| 07/21/2010 | EP2207897A2 A method for predicting a clinical response of a patient suffering from or at risk of developing a neoplastic disease towards a given mode of treatment |
| 07/21/2010 | EP2207896A1 Nucleic acid amplification |
| 07/21/2010 | EP2207895A2 Genetic models for stratification of cancer risk |
| 07/21/2010 | EP2207894A2 Sequence variants for inferring human pigmentation patterns |
| 07/21/2010 | EP2207893A1 Methods and compositions for the detection of beta-lactamases |
| 07/21/2010 | EP2207892A2 Methods for selecting active agents for cancer treatment |
| 07/21/2010 | EP2207891A2 Materials and methods for the generation of transcripts comprising modified nucleotides |
| 07/21/2010 | EP2207879A2 Identification and isolation of fetal cells and nucleic acid |
| 07/21/2010 | EP2207799A2 Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP2007908B1 Methods for increasing accuracy of nucleic acid sequencing |
| 07/21/2010 | EP1885880B1 Amplification and cloning of single dna molecules using rolling circle amplification |
| 07/21/2010 | EP1759019B1 Rapid production of oligonucleotides |
| 07/21/2010 | EP1727901B1 Materials and methods for treatment of cancer |
| 07/21/2010 | EP1694862B1 Methods and compositions for assaying mutations in nucleic acids and their uses in diagnosis of genetic diseases and cancers |
| 07/21/2010 | EP1692307B1 Method for hla typing |
| 07/21/2010 | EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment |
| 07/21/2010 | EP1417493B1 Competitive binding assay for identifying inhibitors of hcv polymerase |
| 07/21/2010 | EP1276896B1 Epitope synchronization in antigen presenting cells |
| 07/21/2010 | CN201530829U Chicken flavor relative gene ADSL SNP parting reagent kit |
| 07/21/2010 | CN201530827U Portable transgenic fast detecting box |
| 07/21/2010 | CN1928116B Rapid determination method of lipase synthetase vitality in non-aqueous phase |
| 07/21/2010 | CN1904069B Measles virus fluorescent augmentation detection kit and detection method |
| 07/21/2010 | CN101784896A Rapid assessment of upper respiratory conditions |
| 07/21/2010 | CN101784676A Egfr inhibitor treatment marker |
| 07/21/2010 | CN101784675A Genetic variants on CHR 15Q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 07/21/2010 | CN101784674A Predictive markers for EGFR inhibitors treatment |
| 07/21/2010 | CN101784673A epigenetic methods |
| 07/21/2010 | CN101784672A Real-time PCR monitoring apparatus |
| 07/21/2010 | CN101784671A An enzyme detection device |
| 07/21/2010 | CN101784663A Methods for isolating long fragment rna from fixed samples |
| 07/21/2010 | CN101782571A Method for detecting antibody subtype |
| 07/21/2010 | CN101782570A Biomolecule competition analysis method and application thereof |
| 07/21/2010 | CN101782509A Cytoactive detection method based on capillary zone electrophoresis mode |
| 07/21/2010 | CN101781687A Flavivirus-detecting gene chip probe and gene chip detection method |
| 07/21/2010 | CN101781686A Fluorescent PCR (Polymerase Chain Reaction) kit for quantitively detecting HPV16/18 type infection |
| 07/21/2010 | CN101781685A Codominant labeling method for identifying wheat polymer glutenin Dx5 and Dx2 subunits |
| 07/21/2010 | CN101781684A Liquid phase chip for CYP19A1 gene SNP (Single Nucleotide Polymorphism) detection and detection method thereof |
| 07/21/2010 | CN101781683A Quick detection method of primary mutation G3635A of Leber hereditary optic nerve pathological mitochondrial DNA |
| 07/21/2010 | CN101781682A Application of CGI-135 gene in judging acute myelogenous leukemia prognosis at early stage |
| 07/21/2010 | CN101781681A Application of PDCD7gene to early judging acute myelogenous leukemia prognosis |
| 07/21/2010 | CN101781680A Method for measuring influencing factors to BAFF-R (B cell-Activating Factor-Receptor) gene promoter activity of human |
| 07/21/2010 | CN101781679A Method for detecting activity of human BAFF-R gene promoter |
| 07/21/2010 | CN101781678A Kit for detecting fusion gene Bcl2-IgH rearrangement |
| 07/21/2010 | CN101781677A Kit for detecting leukemia broad-spectrum marker WT1 gene mRNA expression |